The CBDMEDIC brand has been designated by the Arthritis Foundation as an Impact Sponsor in 2020 and 2021. CBDMEDIC is the first and only CBD brand sold in the food mass drug channel to be designated as an Impact Sponsor of the Arthritis Foundation, recognizing its contribution to this important cause.
The Arthritis Foundation, which continues to pursue a cure for America’s No. 1 cause of disability, provides those battling arthritis with educational resources, advocacy and community connections. The Arthritis Foundation defines an Impact Sponsor as a company or organization that is committed to working with the foundation to ensure that needed tools, resources and support are available for those living with arthritis, by providing funding, raising awareness and engaging employees in our shared mission.
In April, the CBDMEDIC brand also sponsored the Arthritis Foundation’s “Survive & Thrive” live Facebook fundraiser, including three-time NFL champion Rob Gronkowski, among others. The event raised more than $200,000 to support the ongoing work of the Arthritis Foundation.
“People living with arthritis depend on us for guidance and support to improve their everyday lives,” said Ann McNamara, Arthritis Foundation senior vice president of development and community giving. “We are grateful to CBDMEDIC for being an Impact Sponsor. Their support will spark new solutions to relieving arthritis pain and related challenges. We appreciate their commitment to the arthritis community.”
Deanie Elsner, CEO of CBDMEDIC parent company Charlotte’s Web, said the company’s designation as an Impact Sponsor is an important recognition, joining other sponsors in boosting awareness of the Arthritis Foundation’s many resources for millions of people seeking relief.
“We will also share the many resources and support available from the Arthritis Foundation,” Elsner said, “through our own social media and email channels, and our ‘Searching for Answers’ free educational webinars to raise awareness across the country.”
Chronic pain affects millions of Americans each day. According to the Centers for Disease Control and Prevention, at least 54 million Americans have arthritis — and by 2040, that number is expected to jump to 78 million.
Additionally, as cited by a 2019 U.S. Health and Human Services report on pain management, 20 million adults experience high-impact chronic pain that interferes with daily life or work activities. A recent Arthritis Foundation study shows that 92% of those with arthritis say pain interfered with their day-to-day activities. Total medical costs and earnings losses in the U.S. due to arthritis are estimated to be over $300 billion annually.
While hemp-derived CBD products are relative newcomers to food, drug and mass retailers, increasingly those suffering muscle and joint pain are seeking more natural over-the-counter solutions to, literally, take their wellness into their own hands. A Brightfield Group (Q3 2019) study of 3,500 consumers found “managing pain and inflammation” is the No. 1 reason people buy CBD products.
